-
公开(公告)号:US10745478B2
公开(公告)日:2020-08-18
申请号:US15999241
申请日:2017-02-17
Inventor: Rachael Sirianni , Rebecca Cook , Tsafrir Mor , Joseph Blattman
Abstract: Disclosed herein are compositions comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell. Also disclosed herein are methods of treating cancer in a subject, comprising: providing a composition comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell; and treating the cancer by administering a therapeutically effective dosage of the composition to the subject.
-
公开(公告)号:US12018317B2
公开(公告)日:2024-06-25
申请号:US17546953
申请日:2021-12-09
Inventor: Joseph Blattman , Louis Schoettle
IPC: C12Q1/68 , C12N15/87 , C12Q1/6806 , C12Q1/6869
CPC classification number: C12Q1/6806 , C12N15/87 , C12Q1/6869 , C12Q1/6869 , C12Q2563/159 , C12Q2563/179 , C12Q2565/133
Abstract: Methods for incorporation of unique bowtie-barcodes into a nucleic acid origami nanostructure (FIG. 1). In particular, provided herein are methods that facilitate pairing and analysis of nucleic acids from individual cells using, for example, high-throughput next-generation sequencing.
-
公开(公告)号:US11807661B2
公开(公告)日:2023-11-07
申请号:US16929001
申请日:2020-07-14
Inventor: Rachael Sirianni , Rebecca Cook , Tsafrir Mor , Joseph Blattman
IPC: A61K35/00 , C07K16/28 , A61K47/68 , C12N15/82 , A61P35/00 , A61K9/00 , C12N15/86 , C12N15/74 , A61K39/00
CPC classification number: C07K16/28 , A61K9/0019 , A61K47/6817 , A61P35/00 , C07K16/2809 , C12N15/743 , C12N15/8258 , C12N15/86 , A61K2039/505 , C07K2317/56 , C07K2317/622 , C07K2319/33 , C07K2319/55
Abstract: Disclosed herein are compositions comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell. Also disclosed herein are methods of treating cancer in a subject, comprising: providing a composition comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell; and treating the cancer by administering a therapeutically effective dosage of the composition to the subject.
-
公开(公告)号:US20180216102A1
公开(公告)日:2018-08-02
申请号:US15937371
申请日:2018-03-27
Inventor: Joseph Blattman , Hao Yan , Louis Schoettle , Xixi Wei
IPC: C12N15/10 , C12Q1/6806
CPC classification number: C12N15/1062 , B82Y5/00 , B82Y15/00 , C12Q1/6806 , C12Q1/6816 , C12Q1/6881 , C12Q2600/16 , C12Q2563/155
Abstract: Methods for construction of DNA origami nanostructures, as well as for binding, isolation, linking, and deep sequencing information, such as both of TCR alpha and beta CDR3 mRNA, from individual cells within a mixed population of cells without the need for single cell sorting (FIG. 1).
-
公开(公告)号:US20220162674A1
公开(公告)日:2022-05-26
申请号:US17546953
申请日:2021-12-09
Inventor: Joseph Blattman , Louis Schoettle
IPC: C12Q1/6806 , C12Q1/6869 , C12N15/87
Abstract: Methods for incorporation of unique bowtie-barcodes into a nucleic acid origami nanostructure (FIG. 1). In particular, provided herein are methods that facilitate pairing and analysis of nucleic acids from individual cells using, for example, high-throughput next-generation sequencing.
-
公开(公告)号:US20200339679A1
公开(公告)日:2020-10-29
申请号:US16929001
申请日:2020-07-14
Inventor: Rachael Sirianni , Rebecca Cook , Tsafrir Mor , Joseph Blattman
Abstract: Disclosed herein are compositions comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell. Also disclosed herein are methods of treating cancer in a subject, comprising: providing a composition comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell; and treating the cancer by administering a therapeutically effective dosage of the composition to the subject.
-
公开(公告)号:US12257278B2
公开(公告)日:2025-03-25
申请号:US17259849
申请日:2019-07-12
Inventor: Douglas Grant McFadden , John Christie , Joseph Blattman , Mohammed Masmudur Rahman , Nancy Yaneth Villa
IPC: A61K35/768 , A61K35/14 , A61K35/28 , A61K45/06 , A61P35/00 , C07K14/525
Abstract: Disclosed herein, in certain embodiments, is a method of inhibiting or treating a cancer with use of a TNF expressing myxoma virus. Also disclosed herein are methods of inhibiting or treating a cancer with use of a mononuclear peripheral blood cells and/or a bone marrow cells treated with a TNF-expressing myxoma virus. Some aspects relate to engineered myxoma virus and pharmaceutical compositions for use with one or more of the methods described herein.
-
公开(公告)号:US20240092894A1
公开(公告)日:2024-03-21
申请号:US18480038
申请日:2023-10-03
Inventor: Rachael Sirianni , Rebecca Cook , Tsafrir Mor , Joseph Blattman
CPC classification number: C07K16/28 , A61K9/0019 , A61K47/6817 , A61P35/00 , C07K16/2809 , C12N15/743 , C12N15/8258 , C12N15/86 , A61K2039/505 , C07K2317/622
Abstract: Disclosed herein are compositions comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell. Also disclosed herein are methods of treating cancer in a subject, comprising: providing a composition comprising a polypeptide with at least two domains, wherein the first domain is capable of binding CD3 and the second domain is capable of binding to a cancer cell; and treating the cancer by administering a therapeutically effective dosage of the composition to the subject.
-
公开(公告)号:US11466267B2
公开(公告)日:2022-10-11
申请号:US15937371
申请日:2018-03-27
Inventor: Joseph Blattman , Hao Yan , Louis Schoettle , Xixi Wei
IPC: C12Q1/68 , C12N15/10 , C12Q1/6816 , C12Q1/6881 , C12Q1/6806 , B82Y5/00 , B82Y15/00
Abstract: Methods for construction of DNA origami nanostructures, as well as for binding, isolation, linking, and deep sequencing information, such as both of TCR alpha and beta CDR3 mRNA, from individual cells within a mixed population of cells without the need for single cell sorting (FIG. 1).
-
公开(公告)号:US11208681B2
公开(公告)日:2021-12-28
申请号:US16320962
申请日:2017-08-14
Inventor: Joseph Blattman , Louis Schoettle
IPC: C12Q1/68 , C12Q1/6806 , C12Q1/6869 , C12N15/87
Abstract: Methods for incorporation of unique bowtie-barcodes into a nucleic acid origami nanostructure (FIG. 1). In particular, provided herein are methods that facilitate pairing and analysis of nucleic acids from individual cells using, for example, high-throughput next-generation sequencing.
-
-
-
-
-
-
-
-
-